Leyi Yao

468 total citations
20 papers, 338 citations indexed

About

Leyi Yao is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Leyi Yao has authored 20 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Leyi Yao's work include Heme Oxygenase-1 and Carbon Monoxide (6 papers), Neonatal Health and Biochemistry (5 papers) and Ubiquitin and proteasome pathways (5 papers). Leyi Yao is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (6 papers), Neonatal Health and Biochemistry (5 papers) and Ubiquitin and proteasome pathways (5 papers). Leyi Yao collaborates with scholars based in China, United States and United Kingdom. Leyi Yao's co-authors include Jinbao Liu, Daolin Tang, Xin Chen, Yan Ding, Yali Hao, Guanmei Wen, Jinheng Wang, Peiquan Zhang, Jinghong Chen and Zeyuan Liu and has published in prestigious journals such as Oncogene, The FASEB Journal and Free Radical Biology and Medicine.

In The Last Decade

Leyi Yao

18 papers receiving 333 citations

Peers

Leyi Yao

PRM

ONCOL

EPIDE

Shengsong Chen China

Yong-Sheng Tu China

Natalia V. Potoldykova Russia

Zhengyang Zhang China

Xiaowei Shen China

Xiaobo Huang China

Haonan Wang China

Yanghe Zhang China

Ling Shi China

Shengsong Chen China

Leyi Yao

170 ×0.8

80 ×0.7

PRM

64 ×0.8

45 ×0.9

ONCOL

61 ×1.7

EPIDE

Citations per year, relative to Leyi Yao Leyi Yao (= 1×) peers Shengsong Chen

Countries citing papers authored by Leyi Yao

Since Specialization

Citations

This map shows the geographic impact of Leyi Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leyi Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leyi Yao more than expected).

Fields of papers citing papers by Leyi Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leyi Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leyi Yao. The network helps show where Leyi Yao may publish in the future.

Co-authorship network of co-authors of Leyi Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Leyi Yao. A scholar is included among the top collaborators of Leyi Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leyi Yao. Leyi Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yao, Leyi, et al.. (2025). Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis. Cancer Drug Resistance. 8. 15–15. 1 indexed citations

Huang, Hongbiao, et al.. (2025). WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression. Oncogene. 44(48). 4673–4685.

Yao, Leyi, et al.. (2025). UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma. Free Radical Biology and Medicine. 237. 65–75. 1 indexed citations

Zhang, Jiaxing, et al.. (2024). Eupalinolide B suppresses pancreatic cancer by ROS generation and potential cuproptosis. iScience. 27(8). 110496–110496. 12 indexed citations

Yao, Leyi, et al.. (2023). Multi-level model predictive control based multi-objective optimal energy management of integrated energy systems considering uncertainty. Renewable Energy. 212. 523–537. 28 indexed citations

Zhang, Na, Hua Xu, Leyi Yao, et al.. (2023). Bilirubin inhibits lung carcinogenesis by up-regulating cystatin A expression in tumor-infiltrating macrophages. Genes & Diseases. 10(6). 2222–2225. 1 indexed citations

Yao, Leyi, Yan Ding, Qian‐Li Xue, et al.. (2023). Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells. Free Radical Biology and Medicine. 203. 1–10. 50 indexed citations

Liao, Baojian, et al.. (2023). Research Progress on the Role and Mechanism of IL-37 in Liver Diseases. Seminars in Liver Disease. 43(3). 336–350. 3 indexed citations

Yao, Leyi, Qian Zhao, Yan Ding, et al.. (2022). Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells. Cancer Biology and Medicine. 19(7). 1061–1077. 7 indexed citations

10.

Yao, Leyi, Yali Hao, Guanmei Wen, et al.. (2022). Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice. Frontiers in Pharmacology. 13. 809469–809469. 3 indexed citations

11.

Wen, Guanmei, Leyi Yao, Yali Hao, Jinheng Wang, & Jinbao Liu. (2022). Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system. Journal of Translational Medicine. 20(1). 1–1. 54 indexed citations

12.

Li, Yanling, Huiyuan Liu, Keng Chen, et al.. (2021). Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy. Frontiers in Medicine. 8. 706407–706407. 11 indexed citations

13.

Ding, Yan, Xiaofen Li, Qianqian Yang, et al.. (2021). Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30. Cell Death Discovery. 7(1). 211–211. 15 indexed citations

14.

Wen, Xizhi, Leyi Yao, Zhenlong Shao, et al.. (2021). Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling. Frontiers in Oncology. 11. 698888–698888. 3 indexed citations

15.

Wu, Jiawen, Jinghong Chen, Juan Chen, et al.. (2021). Cullin 2‐RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability. The FASEB Journal. 35(8). e21800–e21800. 6 indexed citations

16.

Liao, Yuning, Yuan Liu, Zhenlong Shao, et al.. (2021). A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance. Oncogene. 40(25). 4291–4306. 31 indexed citations

17.

Zhang, Zhiyu, Minkun Jin, Leyi Yao, & Chongfeng Guo. (2021). NIR dual-mode temperature sensor based on FIR technology in BaYF5: Nd3+/Yb3+. Optical Materials. 121. 111607–111607. 11 indexed citations

18.

Li, Yang, Xin Chen, Qianqian Yang, et al.. (2020). Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells. Frontiers in Oncology. 10. 949–949. 87 indexed citations

19.

Chen, Haoyu, Lu Liang, Hua Xu, et al.. (2019). Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life. SSRN Electronic Journal.

20.

Chen, Haoyu, Lu Liang, Jia Xu, et al.. (2019). Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer’s Disease in Late Life. Journal of Alzheimer s Disease. 73(1). 277–295. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact